M
Mauro Boronat
Researcher at Autonomous University of Madrid
Publications - 30
Citations - 1026
Mauro Boronat is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Diabetes mellitus & Population. The author has an hindex of 15, co-authored 24 publications receiving 959 citations.
Papers
More filters
Journal ArticleDOI
The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease
Javier Estrada,Mauro Boronat,Mercedes Mielgo,Rosa Magallón,Isabel Millán,Santiago Diez,Tomás Lucas,Barceló B +7 more
TL;DR: Pituitary irradiation is an effective and well-tolerated treatment for patients with Cushing's disease in whom transsphenoidal surgery is unsuccessful and none of the 25 patients had a relapse of Cushing't disease after remission was achieved.
Journal ArticleDOI
Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation: The Telde Study
Francisco J Nóvoa,Mauro Boronat,Pedro Saavedra,Juan M Díaz-Cremades,Valois F Varillas,Maria Alberiche,Armando Carrillo +6 more
TL;DR: Individuals with IGR, especially those with IFG/IGT, have increased values of cardiovascular risk factors and higher indexes of insulin resistance and groups with isolated IFG and isolated IGT present similar cardiovascular risk profiles.
Journal ArticleDOI
Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results
TL;DR: This study evaluates the results of IPS sampling in patients with Cushing's disease, and compares them with both imaging findings and transsphenoidal examination.
Journal ArticleDOI
Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria
TL;DR: The prevalence and the determinants of diabetes mellitus and impaired glucose regulation (IGR) in an adult Canarian population are estimated and the results show clear trends in type 2 diabetes and IGR.
Journal ArticleDOI
Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation.
Mauro Boronat,Dunia Marrero,Yaiza López-Plasencia,Miguel Barber,Yaiza Schamann,Francisco J Nóvoa +5 more
TL;DR: Treatment with ketoconazole during the critical period of organogenesis did not cause congenital birth defects to the male fetus of a woman with Cushing's disease, and the patient delivered a healthy male infant with normal external genitalia.